The apparently very short time interval between NOX reporting the preliminary results for treatment of pancreatic cancer and FDA Orphan drug status is remarkable. Looks like the FDA sees this treatment as a potential significant breakthrough and have wasted no time in granting the Orphan Status
Ann: US FDA grants Orphan Drug Designation for CRO-67, page-2
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.009(9.38%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.5¢ | 9.6¢ | $3.808K | 37.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10937 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 36068 | 2 |
View Market Depth
| Last trade - 15.59pm 02/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |